Tarek Samad, PhD, is a Pfizer Investigator and the Head of the Neuroinflammation Research Group at Pfizer’s Neuroscience Research Unit. The group investigates emerging scientific concepts, and identifies and validates therapeutic targets for innovative medicines in neurological and neurodegenerative disorders.
Over the past ten years, Dr. Samad’s work in academic and pharmaceutical arenas has focused on studying adaptive and maladaptive inflammatory and neuroimmune interactions and their implications in neurodegenerative diseases.